Nuveen Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-737,464
| Closed | -$494K | – | 3405 |
|
|
2024
Q1 | $494K | Hold |
737,464
| – | – | ﹤0.01% | 2978 |
|
|
2023
Q4 | $401K | Buy |
737,464
+20,936
| +3% | +$11.4K | ﹤0.01% | 3075 |
|
|
2023
Q3 | $430K | Sell |
716,528
-2,775
| -0.4% | -$1.66K | ﹤0.01% | 2891 |
|
|
2023
Q2 | $935K | Sell |
719,303
-664,326
| -48% | -$864K | ﹤0.01% | 2682 |
|
|
2023
Q1 | $2.44M | Sell |
1,383,629
-1,948,972
| -58% | -$3.43M | ﹤0.01% | 2260 |
|
|
2022
Q4 | $10.5M | Sell |
3,332,601
-23,228
| -0.7% | -$72.9K | ﹤0.01% | 1459 |
|
|
2022
Q3 | $16.4M | Buy |
3,355,829
+2,267,632
| +208% | +$11.1M | 0.01% | 1148 |
|
|
2022
Q2 | $4.51M | Sell |
1,088,197
-144,010
| -12% | -$596K | ﹤0.01% | 2012 |
|
|
2022
Q1 | $7.12M | Sell |
1,232,207
-64,659
| -5% | -$374K | ﹤0.01% | 1855 |
|
|
2021
Q4 | $9.26M | Sell |
1,296,866
-137,659
| -10% | -$983K | ﹤0.01% | 1745 |
|
|
2021
Q3 | $13.7M | Buy |
1,434,525
+36,079
| +3% | +$345K | ﹤0.01% | 1553 |
|
|
2021
Q2 | $16.7M | Sell |
1,398,446
-59,903
| -4% | -$717K | 0.01% | 1509 |
|
|
2021
Q1 | $18.3M | Buy |
1,458,349
+18,089
| +1% | +$227K | 0.01% | 1392 |
|
|
2020
Q4 | $22.5M | Buy |
1,440,260
+73,749
| +5% | +$1.15M | 0.01% | 1190 |
|
|
2020
Q3 | $12.9M | Buy |
1,366,511
+662,875
| +94% | +$6.26M | 0.01% | 1346 |
|
|
2020
Q2 | $6.3M | Buy |
703,636
+26,370
| +4% | +$236K | ﹤0.01% | 1767 |
|
|
2020
Q1 | $4.31M | Sell |
677,266
-95,582
| -12% | -$609K | ﹤0.01% | 1797 |
|
|
2019
Q4 | $6.47M | Buy |
772,848
+32,337
| +4% | +$271K | ﹤0.01% | 1847 |
|
|
2019
Q3 | $6.7M | Sell |
740,511
-50,171
| -6% | -$454K | ﹤0.01% | 1798 |
|
|
2019
Q2 | $8.52M | Buy |
+790,682
| New | +$8.52M | ﹤0.01% | 1699 |
|